Afficher la couverture '1022MO Predicting overall survival of patients with melanoma and NSCLC treated with immunotherapy using AI combining total tumor volume and tumor heterogeneity on CT-Scans | Dawi, Lama' en grand format
/5

0 avis

1022MO Predicting overall survival of patients with melanoma and NSCLC treated with immunotherapy using AI combining total tumor volume and tumor heterogeneity on CT-Scans

Archive ouverte

Dawi, Lama | Ammari, Samy | Belkouchi, Younes | Hadchiti, Joya | Lawrance, L. | Wirth, F. | Bertin, Aline | Morer, S. | Billet, N. | Balleyguier, Corinne | Cournede, Paul-Henry | Talbot, Hugues | Lassau, Nathalie

Edité par CCSD -

International audience. Using total tumor volume and AI tumor heterogeneity from CT scans, it may be possible to predict the prognosis of oncology patients, identify those who could benefit from immunotherapy, and provide valuable guidance for treatment.

Consulter en ligne

Suggestions

Du même auteur

Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases

Archive ouverte | Dawi, Lama | CCSD

International audience. Tumor fraction at liquid biopsy was weakly correlated with the total tumor volume at contrast-enhanced CT and did not accurately reflect the tumor burden at contrast-enhanced CT.

Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients

Archive ouverte | Barbe, Rémy | CCSD

International audience. BackgroundThis retrospective study determined survival responses to immune checkpoint inhibitors (ICIs), comparing mono- (mono) and combo-immunotherapy (combo) in patients with microsatellite...

Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Archive ouverte | Belkouchi, Younes | CCSD

International audience. Abstract Purpose: The objective of the study is to propose the immunotherapy progression decision (iPD) score, a practical tool based on patient features that are available at the first evalu...

Chargement des enrichissements...